Menopause (New York, N.Y.), cilt.29, sa.00, ss.1071-1076, 2022 (SCI-Expanded)
Abstract
Objective: The aim of this study was to investigate whether whole blood viscosity and plasma viscosity are associated with the severity of postmenopausal symptoms using the Menopause Rating Scale (MRS).
Methods: This study included 108 postmenopausal women admitted to menopause clinics. Participants were divided into two groups according to their MRS scores. Groups 1 (n = 52) and 2 (n = 56) were composed of healthy postmen- opausal women with MRS scores of <14 and ≥14 points, respectively. The clinical findings and hemorheological pa- rameters were compared between the two groups.
Results: Comparing plasma viscosity levels between the two groups showed that group 1 had 1.25 ± 0.08 centipoise, whereas group 2 had 1.30 ± 0.10 centipoise ( P = 0.03). The difference in plasma viscosity between the two groups persisted after adjustment for age (1.24 ± 0.08 vs 1.31 ± 0.10; P < 0.001). Plasma viscosity was also significantly cor- related with age (r = 0.384, P < 0.001), menopausal duration (r = 0.362, P < 0.001), and urogenital symptoms (r = 410, P < 0.001).
Conclusions: Increased plasma viscosity levels were significantly associated with selected postmenopausal symp- toms, independent of age.
Key Words: Hemorheology – Menopausal symptoms – Menopause Rating Scale – Plasma viscosity – Urogenital symptoms.